Loratadine reduces the expression of ICAM-1

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 5, 1998, Pages 545-546

  Ciprandi, G ^a   Catrullo, A ^b   Cerqueti, R ^b   Tosca, M ^b   Fiorino, N ^b   Canonica, G W ^b  

^a Allerg and Clin Immunology Service   (Italy)

^b NONE

Author keywords

Allergen challenge; Conjunctivae; Epithelia; ICAM 1; Leratadine

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LORATADINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ADULT; ALLERGIC CONJUNCTIVITIS; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOMODULATION; KERATOCONJUNCTIVITIS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0031864589     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb04099.x     Document Type: Article

References (2)

1. Ciprandi G, Buscaglia S, Pesce GP, Villaggio B, Bagnasco M, Canonica GW. Allergie subjects express intercellular adhesion molecules-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge. J Allergy Clin Immunol 1993;91:783-92.
2. Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Danzig M, Canonica GW. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression. Clin Exp Allergy 1997;27:1175-83.